NCT00543426

Fuzheng Huayu Tablets Against Posthepatitic Cirrhosis

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 200 (actual)
• Sponsor: Shanghai University of Traditional Chinese Medicine · Academic / Other
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Not accepted

Summary

The primary purpose of the trial is adopted Fuzheng Huayu tablets against posthepatitic cirrhosis, and to build a standard evaluation system for efficacy of traditional Chinese medicine (TCM). The second purpose is according to the international clinical guideline and the specialty of TCM to build a standard clinical trial regulation for traditional Chinese medicine.

Conditions

• Posthepatitic Cirrhosis

Interventions

Type	Name	Description
DRUG	Fuzheng Huayu Tablets	Tablet,three times a day,four tablets one time
DRUG	sham Fuzheng Huayu Tablets (placebo)	Tablet, three times a day, four tablets one time

Timeline

• Start date: 2007-09-01
• Primary completion: 2009-05-01
• Completion: 2009-06-01
• First posted: 2007-10-15
• Last updated: 2013-03-07

Locations

1 site across 1 country: China